EP1224309A2 - Modification post-traductionnelle de proteines de recombinaison produites dans les plantes - Google Patents
Modification post-traductionnelle de proteines de recombinaison produites dans les plantesInfo
- Publication number
- EP1224309A2 EP1224309A2 EP00978257A EP00978257A EP1224309A2 EP 1224309 A2 EP1224309 A2 EP 1224309A2 EP 00978257 A EP00978257 A EP 00978257A EP 00978257 A EP00978257 A EP 00978257A EP 1224309 A2 EP1224309 A2 EP 1224309A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- plant
- host system
- post
- plant host
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
Abstract
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16075899P | 1999-10-21 | 1999-10-21 | |
US19528200P | 2000-04-07 | 2000-04-07 | |
US195282P | 2000-04-07 | ||
PCT/US2000/029027 WO2001029242A2 (fr) | 1999-10-21 | 2000-10-20 | Modification post-traductionnelle de proteines de recombinaison produites dans les plantes |
US160758P | 2009-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1224309A2 true EP1224309A2 (fr) | 2002-07-24 |
Family
ID=26857200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00978257A Withdrawn EP1224309A2 (fr) | 1999-10-21 | 2000-10-20 | Modification post-traductionnelle de proteines de recombinaison produites dans les plantes |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1224309A2 (fr) |
AU (1) | AU1573601A (fr) |
BR (1) | BR0014945A (fr) |
CA (1) | CA2388432A1 (fr) |
WO (1) | WO2001029242A2 (fr) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
NZ512185A (en) | 1998-12-09 | 2004-02-27 | Dow Chemical Co | A method for manufacturing glycoproteins having human- type glycosylation in plant cells |
BRPI0015031B1 (pt) * | 1999-10-26 | 2017-05-30 | Plant Res Int B V | método para prover uma planta transgênica capaz de expressar um anticorpo com galactosilação terminal e método para obtenção de uma glicoproteína desejada ou fragmento funcional da mesma |
AT409381B (de) * | 2000-03-03 | 2002-07-25 | Gloessl Josef Dr | Xylosyltransferase-gen |
CA2405709A1 (fr) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Proteines fusionnees a l'albumine |
US7598055B2 (en) * | 2000-06-28 | 2009-10-06 | Glycofi, Inc. | N-acetylglucosaminyltransferase III expression in lower eukaryotes |
US7632983B2 (en) | 2000-07-31 | 2009-12-15 | Biolex Therapeutics, Inc. | Expression of monoclonal antibodies in duckweed |
IL156879A0 (en) * | 2001-01-19 | 2004-02-08 | Dow Chemical Co | Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
EP1399572A4 (fr) * | 2001-06-05 | 2005-02-09 | Karen K Oishi | Expression genique et production de proteines tgf-b comprenant une substance inhibitrice mullerienne bioactive issue de vegetaux |
JP2004535192A (ja) * | 2001-06-08 | 2004-11-25 | イコン ジェネティクス インコーポレイティッド | 植物中におけるタンパク質の産生 |
CA2471363C (fr) | 2001-12-21 | 2014-02-11 | Human Genome Sciences, Inc. | Proteines hybrides d'albumine |
AU2008202355B2 (en) * | 2002-03-19 | 2011-04-07 | Stichting Dienst Landbouwkundig Onderzoek | Optimizing glycan processing in plants |
EP1485492B1 (fr) * | 2002-03-19 | 2011-12-21 | Stichting Dienst Landbouwkundig Onderzoek | Expression de gntiii (udp-n-acetylglucosamine: beta -d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) dans des plantes. |
EP2339004B1 (fr) | 2002-03-19 | 2015-02-25 | Stichting Dienst Landbouwkundig Onderzoek | Optimisation du traitement du glycane chez les plantes |
CL2003002461A1 (es) | 2002-11-27 | 2005-01-07 | Dow Chemical Company Agroscien | Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas. |
AU2003294912B2 (en) * | 2002-12-20 | 2009-06-04 | Greenovation Biotech Gmbh | Production of heterologous glycosylated proteins in bryophyte cells |
ATE335084T1 (de) * | 2002-12-20 | 2006-08-15 | Greenovation Biotech Gmbh | Verfahren zur herstellung von glykosylierten proteinen in bryophyten zellen |
AU2003298984A1 (en) * | 2002-12-27 | 2004-08-23 | Shenzhen Tsinghua Yuanxing Bio-Pharm Science And Technology Co., Ltd. | Method of preparing a vaccine and anti-tumor vaccines |
NZ541503A (en) * | 2003-01-22 | 2008-09-26 | Glycart Biotechnology Ag | Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function |
CN100427599C (zh) * | 2003-12-26 | 2008-10-22 | 吉林大学第一医院 | Albsin/il-18mat杂交细胞因子 |
US8455717B2 (en) | 2004-09-29 | 2013-06-04 | Collplant Ltd. | Collagen producing plants and methods of generating and using same |
EP1809751B1 (fr) * | 2004-09-29 | 2010-09-01 | CollPlant Ltd. | Collagène recombinant produit dans une plante |
AU2007205939B2 (en) | 2006-01-17 | 2012-12-13 | Synthon Biopharmaceuticals B.V. | Compositions and methods for humanization and optimization of N-glycans in plants |
EP1816201A1 (fr) | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Facteur de coagulation VIIa modifié ayant une stabilité 'half-life' améliorée |
BRPI0716711A2 (pt) * | 2006-11-08 | 2013-10-01 | Centre Nat Rech Scient | "seqÜencia de aminoÁcido, proteÍna recombinanate, seqÜncia de Ácido nuclÉico, vetor de Ácido nuclÉico, cÉlula vegetal, vegetal e mÉtodo para produÇço de um polipeptideo modificado pàs-traducionalmente" |
CA2684370C (fr) | 2007-04-17 | 2017-10-17 | Plant Research International B.V. | Glycosylation de type mammifere dans des plantes par l'expression de glycosyltransferases non mammiferes |
HUE031698T2 (en) * | 2007-06-15 | 2017-07-28 | Medicago Inc | Modification of glycoprotein production in plants |
US20100242128A1 (en) * | 2007-10-31 | 2010-09-23 | Bayer BioSceince NV | Method to produce modified plants with altered n-glycosylation pattern |
MX2010004910A (es) | 2007-11-08 | 2010-05-14 | Neogenix Oncology Inc | Anticuerpos monoclonales recombinantes y antigenos correspondientes para canceres colonico y pancreatico. |
WO2010006452A1 (fr) | 2008-07-18 | 2010-01-21 | Medicago Inc. | Nouvel épitope d’immunisation contre l’influenzavirus |
US20140302999A1 (en) * | 2011-11-03 | 2014-10-09 | Magdalena Leszczyniecka | Method for determination of pharmacological properties of recombinant proteins |
WO2014130922A1 (fr) | 2013-02-25 | 2014-08-28 | Trustees Of Boston University | Compositions et procédés pour le traitement d'infections fongiques |
GB201308120D0 (en) * | 2013-05-06 | 2013-06-12 | Baden Wuerttemberg Stiftung Gmbh | Recombinant protein and method for its production |
JP6450381B2 (ja) | 2013-07-05 | 2019-01-09 | ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャリゼーション | がんを処置するための可溶性mic中和モノクローナル抗体 |
WO2015050005A1 (fr) * | 2013-10-02 | 2015-04-09 | 株式会社UniBio | Composition protéique stimulant la prolifération cellulaire via le récepteur de l'egf |
EP3221455B1 (fr) | 2014-11-20 | 2020-08-12 | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. | Compositions et procédés de production de polypeptides présentant un schéma de glycosylation modifié dans des cellules végétales |
SG10202008378UA (en) * | 2016-04-15 | 2020-10-29 | Regenxbio Inc | Treatment of ocular diseases with fully-human post-translationally modified anti-vegf fab |
EP3452103A1 (fr) | 2016-04-15 | 2019-03-13 | The Trustees Of The University Of Pennsylvania | Composition pour le traitement de la dégénérescence maculaire liée a l'âge exsudative |
WO2020176972A1 (fr) * | 2019-03-06 | 2020-09-10 | Plantform Corporation | Vecteurs d'adn-t ayant des séquences 5' modifiées en amont d'enzymes de modification post-traductionnelles et leurs procédés d'utilisation |
KR102594083B1 (ko) | 2020-07-07 | 2023-10-25 | 칸큐어 엘엘씨 | Mic 항체 및 결합제 및 이의 사용 방법 |
JP2024505600A (ja) | 2021-02-03 | 2024-02-06 | モーツァルト セラピューティクス, インコーポレイテッド | 結合剤およびそれを使用する方法 |
CN117279664A (zh) | 2021-04-10 | 2023-12-22 | 普方生物制药美国公司 | Folr1结合剂、其偶联物及其使用方法 |
CN117203238A (zh) | 2021-04-23 | 2023-12-08 | 普方生物制药美国公司 | Cd70结合剂、其偶联物及其使用方法 |
TW202320857A (zh) | 2021-07-06 | 2023-06-01 | 美商普方生物製藥美國公司 | 連接子、藥物連接子及其結合物及其使用方法 |
WO2023076876A1 (fr) | 2021-10-26 | 2023-05-04 | Mozart Therapeutics, Inc. | Modulation de réponses immunitaires à des vecteurs viraux |
WO2023092099A1 (fr) | 2021-11-19 | 2023-05-25 | Ardeagen Corporation | Agents de liaison de gpc3, leurs conjugués et leurs procédés d'utilisation |
WO2024030956A2 (fr) | 2022-08-03 | 2024-02-08 | Mozart Therapeutics, Inc. | Agents de liaison se liant spécifiquement à cd39 et leurs méthodes d'utilisation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723755A (en) * | 1995-05-16 | 1998-03-03 | Francis E. Lefaivre | Large scale production of human or animal proteins using plant bioreactors |
DE19754622A1 (de) * | 1997-12-09 | 1999-06-10 | Antje Von Dr Schaewen | Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität |
NZ512185A (en) * | 1998-12-09 | 2004-02-27 | Dow Chemical Co | A method for manufacturing glycoproteins having human- type glycosylation in plant cells |
WO2001031044A1 (fr) * | 1999-10-26 | 2001-05-03 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Gonadotrophines dans les plantes |
BRPI0015031B1 (pt) * | 1999-10-26 | 2017-05-30 | Plant Res Int B V | método para prover uma planta transgênica capaz de expressar um anticorpo com galactosilação terminal e método para obtenção de uma glicoproteína desejada ou fragmento funcional da mesma |
-
2000
- 2000-10-20 AU AU15736/01A patent/AU1573601A/en not_active Abandoned
- 2000-10-20 EP EP00978257A patent/EP1224309A2/fr not_active Withdrawn
- 2000-10-20 CA CA002388432A patent/CA2388432A1/fr not_active Abandoned
- 2000-10-20 WO PCT/US2000/029027 patent/WO2001029242A2/fr not_active Application Discontinuation
- 2000-10-20 BR BR0014945-4A patent/BR0014945A/pt not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO0129242A3 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001029242A2 (fr) | 2001-04-26 |
AU1573601A (en) | 2001-04-30 |
BR0014945A (pt) | 2004-08-31 |
WO2001029242A3 (fr) | 2002-02-21 |
CA2388432A1 (fr) | 2001-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001029242A2 (fr) | Modification post-traductionnelle de proteines de recombinaison produites dans les plantes | |
CN100532558C (zh) | 在植物中优化聚糖生成 | |
US9255277B2 (en) | GNTIII expression in plants | |
US8058512B2 (en) | Gene expression and production of TGF-β proteins including bioactive mullerian inhibiting substance from plants | |
AU760394B2 (en) | Vegetable (GntI) sequences and the use thereof to obtain plants with a reduced or lack of N-acetylglucosaminyltransferase I (GnTI) activity | |
AU2012202479B2 (en) | Optimizing glycan processing in plants | |
EP3305893A1 (fr) | Production de polypeptides polysialylées dans des plantes et des cellules de plantes | |
US20120036600A9 (en) | Method for generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins | |
KR101606918B1 (ko) | 인간화 저-만노스형 엔-당질 합성 식물 및 이의 용도 | |
AU2013205260B2 (en) | Optimizing glycan processing in plants | |
AU2008202355B2 (en) | Optimizing glycan processing in plants | |
AU2016203395A1 (en) | Optimizing glycan processing in plants | |
AU2002312328A1 (en) | Gene expression and production of TGF-B proteins including bioactive mullerian inhibiting substance from plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020515 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20020515;LT PAYMENT 20020515;LV PAYMENT 20020515;MK PAYMENT 20020515;RO PAYMENT 20020515;SI PAYMENT 20020515 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MONSANTO TECHNOLOGY LLC |
|
17Q | First examination report despatched |
Effective date: 20031201 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040614 |